You just read:

Janssen to Present Latest Data for Type 2 Diabetes Treatment INVOKANA® (canagliflozin) at American Diabetes Association 74th Scientific Sessions®

News provided by

Janssen Research & Development, LLC

Jun 10, 2014, 08:56 ET